612
Views
13
CrossRef citations to date
0
Altmetric
Author's View

Prognostic value of the immune microenvironment in lung adenocarcinoma

, &
Article: e24036 | Received 15 Feb 2013, Accepted 17 Feb 2013, Published online: 01 May 2013

References

  • Pagès F, Kirilovsky A, Mlecnik B, Asslaber M, Tosolini M, Bindea G, et al. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. J Clin Oncol 2009; 27:5944 - 51; http://dx.doi.org/10.1200/JCO.2008.19.6147; PMID: 19858404
  • Al-Shibli KI, Donnem T, Al-Saad S, Persson M, Bremnes RM, Busund LT. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer. Clin Cancer Res 2008; 14:5220 - 7; http://dx.doi.org/10.1158/1078-0432.CCR-08-0133; PMID: 18698040
  • Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 2007; 25:2586 - 93; http://dx.doi.org/10.1200/JCO.2006.09.4565; PMID: 17577038
  • Suzuki K, Kadota K, Sima CS, Nitadori J, Rusch VW, Travis WD, et al. Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence. J Clin Oncol 2013; 31:490 - 8; http://dx.doi.org/10.1200/JCO.2012.45.2052; PMID: 23269987
  • Suzuki K, Kachala SS, Kadota K, Shen R, Mo Q, Beer DG, et al. Prognostic immune markers in non-small cell lung cancer. Clin Cancer Res 2011; 17:5247 - 56; http://dx.doi.org/10.1158/1078-0432.CCR-10-2805; PMID: 21659461
  • Airoldi I, Di Carlo E, Cocco C, Sorrentino C, Fais F, Cilli M, et al. Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy. Blood 2005; 106:3846 - 53; http://dx.doi.org/10.1182/blood-2005-05-2034; PMID: 16081683
  • Airoldi I, Di Carlo E, Cocco C, Caci E, Cilli M, Sorrentino C, et al. IL-12 can target human lung adenocarcinoma cells and normal bronchial epithelial cells surrounding tumor lesions. PLoS One 2009; 4:e6119; http://dx.doi.org/10.1371/journal.pone.0006119; PMID: 19582164
  • Pegram HJ, Lee JC, Hayman EG, Imperato GH, Tedder TF, Sadelain M, et al. Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning. Blood 2012; 119:4133 - 41; http://dx.doi.org/10.1182/blood-2011-12-400044; PMID: 22354001
  • Rochman Y, Spolski R, Leonard WJ. New insights into the regulation of T cells by gamma(c) family cytokines. Nat Rev Immunol 2009; 9:480 - 90; http://dx.doi.org/10.1038/nri2580; PMID: 19543225
  • Ming J, Zhang Q, Qiu X, Wang E. Interleukin 7/interleukin 7 receptor induce c-Fos/c-Jun-dependent vascular endothelial growth factor-D up-regulation: a mechanism of lymphangiogenesis in lung cancer. Eur J Cancer 2009; 45:866 - 73; http://dx.doi.org/10.1016/j.ejca.2008.12.006; PMID: 19136250